Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Tran

Showing results (1-10 of 121) with videos related to

Pageof 13
Sort By:
Cancer Journal (Sudbury, Mass.)|July 26, 2022
Neoantigen-Specific T Cells in Adoptive Cell TherapyEric Tran
The Journal of Clinical Investigation|November 1, 2024
More T cell receptors to the RAScue in cancer?Eric Tran
Oncotarget|July 22, 2014
T-cell therapy against cancer mutationsEric Tran, Steven A Rosenberg
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 18, 2025
Diffuse large B-cell lymphoma: examining evolving patterns in mortality, incidence, and demographicsSilpa Choday, Eric Tran, Miguel Gonzalez
L' Orthodontie Francaise|April 28, 2023
Orofacial myofunctional reeducation assisted by a prefabricated reeducation appliance: a systematic review of the literaturePhilippe Amat, Eric Tran Lu Y
The New England Journal of Medicine|August 10, 2022
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer. ReplyEric Tran, Walter J Urba, Rom Leidner
Biorxiv : the Preprint Server for Biology|February 12, 2026
Ecological context structures duplication and mobilization of antibiotic and metal resistance genes in bacteriaEric Tran, Priscilla N Xu, Raquel Assis
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferationHeather M Lockyer, Eric Tran, Brad H Nelson
American Journal of Clinical Oncology|April 22, 2009
Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancerEric Tran, Luis Souhami, Simon Tanguay, et al.
Nature Immunology|February 16, 2017
'Final common pathway' of human cancer immunotherapy: targeting random somatic mutationsEric Tran, Paul F Robbins, Steven A Rosenberg
Pageof 13

Showing results (1-10 of 121) with videos related to

Sort By:
Pageof 13
Cancer Journal (Sudbury, Mass.)|July 26, 2022
Neoantigen-Specific T Cells in Adoptive Cell TherapyEric Tran
The Journal of Clinical Investigation|November 1, 2024
More T cell receptors to the RAScue in cancer?Eric Tran
Oncotarget|July 22, 2014
T-cell therapy against cancer mutationsEric Tran, Steven A Rosenberg
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|February 18, 2025
Diffuse large B-cell lymphoma: examining evolving patterns in mortality, incidence, and demographicsSilpa Choday, Eric Tran, Miguel Gonzalez
L' Orthodontie Francaise|April 28, 2023
Orofacial myofunctional reeducation assisted by a prefabricated reeducation appliance: a systematic review of the literaturePhilippe Amat, Eric Tran Lu Y
The New England Journal of Medicine|August 10, 2022
Neoantigen T-Cell Receptor Gene Therapy in Pancreatic Cancer. ReplyEric Tran, Walter J Urba, Rom Leidner
Biorxiv : the Preprint Server for Biology|February 12, 2026
Ecological context structures duplication and mobilization of antibiotic and metal resistance genes in bacteriaEric Tran, Priscilla N Xu, Raquel Assis
Journal of Immunology (Baltimore, Md. : 1950)|October 4, 2007
STAT5 is essential for Akt/p70S6 kinase activity during IL-2-induced lymphocyte proliferationHeather M Lockyer, Eric Tran, Brad H Nelson
American Journal of Clinical Oncology|April 22, 2009
Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancerEric Tran, Luis Souhami, Simon Tanguay, et al.
Nature Immunology|February 16, 2017
'Final common pathway' of human cancer immunotherapy: targeting random somatic mutationsEric Tran, Paul F Robbins, Steven A Rosenberg
Pageof 13